Goldman Sachs keeps a Buy rating with an HK$18.88 price target on China Medical System, which is being added to the firm’s new “APAC Conviction List – Directors’ Cut.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CHSYF: